AU1597199A - Methods and compositions for inhibiting hiv infectivity and blocking chemokine activity - Google Patents

Methods and compositions for inhibiting hiv infectivity and blocking chemokine activity

Info

Publication number
AU1597199A
AU1597199A AU15971/99A AU1597199A AU1597199A AU 1597199 A AU1597199 A AU 1597199A AU 15971/99 A AU15971/99 A AU 15971/99A AU 1597199 A AU1597199 A AU 1597199A AU 1597199 A AU1597199 A AU 1597199A
Authority
AU
Australia
Prior art keywords
compositions
methods
inhibiting hiv
hiv infectivity
chemokine activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU15971/99A
Inventor
Andrea Rene Crombie
Jeffrey C Laurence
Ralph L. Nachman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cornell Research Foundation Inc
Original Assignee
Cornell Research Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cornell Research Foundation Inc filed Critical Cornell Research Foundation Inc
Publication of AU1597199A publication Critical patent/AU1597199A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU15971/99A 1997-11-25 1998-11-24 Methods and compositions for inhibiting hiv infectivity and blocking chemokine activity Abandoned AU1597199A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US6629497P 1997-11-25 1997-11-25
US60066294 1997-11-25
US7887398P 1998-03-20 1998-03-20
US60078873 1998-03-20
PCT/US1998/024905 WO1999026649A1 (en) 1997-11-25 1998-11-24 Methods and compositions for inhibiting hiv infectivity and blocking chemokine activity

Publications (1)

Publication Number Publication Date
AU1597199A true AU1597199A (en) 1999-06-15

Family

ID=26746580

Family Applications (1)

Application Number Title Priority Date Filing Date
AU15971/99A Abandoned AU1597199A (en) 1997-11-25 1998-11-24 Methods and compositions for inhibiting hiv infectivity and blocking chemokine activity

Country Status (2)

Country Link
AU (1) AU1597199A (en)
WO (1) WO1999026649A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI233361B (en) * 2001-04-13 2005-06-01 Gen Hospital Corp Methods of preventing UVB-induced skin damage

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992017499A1 (en) * 1991-04-08 1992-10-15 Cornell Research Foundation, Inc. A unique hexapeptide derived from thrombospondin and its uses
AU5699996A (en) * 1995-06-02 1996-12-18 Allelix Biopharmaceuticals Inc. Anti-inflammatory thrombospondin-derived peptides

Also Published As

Publication number Publication date
WO1999026649A1 (en) 1999-06-03
WO1999026649A9 (en) 2000-07-06

Similar Documents

Publication Publication Date Title
AU9297898A (en) Thioalkyl compounds, methods, and compositions for inhibiting parp activity
AU9298098A (en) Amino-substituted compounds, methods, and compositions for inhibiting parp activity
AU3434393A (en) Targeted virus
AU2126097A (en) Dental compounds, compositions and products
AU8262898A (en) Dental isolator
HUP0000965A3 (en) Pyrrolidine derivatives having phospolipase a2 inhibitory activity and pharmaceutical compositions containing the same
AU4723296A (en) Compositions having depigmenting activity, and uses thereof
AU1690399A (en) Neovascularization inhibitor containing dienogest as the active ingredient
AU9298198A (en) Di-n-heterocyclic compounds, methods, and compositions for inhibiting parp activity
EP1067130A4 (en) Triazolo derivatives and chemokine inhibitors containing the same as the active ingredient
AU1825099A (en) Combination trap, holding pen and chum pot
AU1408300A (en) Hiv infection inhibitors
AU7261898A (en) Methods for viral inactivation and compositions for use in same
AU1390199A (en) Compositions and methods for inhibiting the activity of certain genes
HUP0001940A3 (en) Benzisothiazole derivatives, their use and pharmaceutical compositions containing them
AU4806497A (en) Glyoxylic compound comprising one or more active ingredient
AU1907995A (en) Active muffler
AU1733797A (en) Particulate carriers and pharmaceutical compositions containing the same
IL106290A0 (en) Enzyme inhibitors,their preparation and pharmaceutical compositions containing them
AU4132096A (en) Compositions and methods for interfering with hepatitis b virus infection
AU1597199A (en) Methods and compositions for inhibiting hiv infectivity and blocking chemokine activity
AU1878995A (en) Oligonucleotides with anti-epstein-barr virus activity
AU6271098A (en) Hiv integrase inhibitors
AU1046799A (en) Compound, composition and use
AU7107698A (en) Aami specification optimized truncated exponential waveform

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase